Stock Market Reviews

CAH (Cardinal Health, Inc.) News

Get the latest news, insights, and market updates on CAH (Cardinal Health, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Here's Why You Should Add DaVita Stock to Your Portfolio for Now
  DVA is gaining attention after strong Q4 results and steady global expansion, though its heavy reliance on commercial insurers remains a concern.
  Mar 6, 2026 - $CAH
• BDX Secures CE Mark for Revello Stent to Treat Iliac Artery Disease
  BD wins CE Mark for its Revello vascular covered stent for iliac artery disease, expanding its peripheral vascular portfolio in the growing PAD treatment market.
  Mar 6, 2026 - $CAH
• Why Cardinal Health May Be a Best Buy for the Coming Stagflation
  This morning’s jobs report landed hard. Nonfarm payrolls plunged by 92,000 jobs, shattering expectations of a 55,000 gain. Unemployment climbed to 4.4%, while average hourly earnings jumped 0.4% month-over-month — well above the 0.3% consensus. The Federal Reserve is now caught in a classic stagflation trap: slashing rates risks reigniting inflation, yet raising them is ... Why Cardinal Health May Be a Best Buy for the Coming Stagflation
  Mar 6, 2026 - $CAH
• EYE Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise
  National Vision's Q4 earnings and revenues top estimates as margins expand and comparable sales rise, sending shares up after strong traffic and ticket growth.
  Mar 5, 2026 - $CAH
• Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?
  According to the average brokerage recommendation (ABR), one should invest in Cardinal (CAH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
  Mar 5, 2026 - $CAH
• BD Gains FDA Clearance for Surgiphor 1000mL Surgical Irrigation System
  BDX wins FDA 510(k) clearance for Surgiphor 1000mL antimicrobial irrigation system, expanding its surgical irrigation portfolio with a powered lavage option.
  Mar 5, 2026 - $CAH
• CryoPort Q4 Earnings Call Highlights
  CryoPort (NASDAQ:CYRX) reported fiscal 2025 results that management characterized as a year of “strong progress,” highlighted by revenue above prior guidance, continued commercial cell and gene therapy momentum, and further steps toward profitability. Fiscal 2025 results and mix For the full year,
  Mar 4, 2026 - $CAH
• Q4 Earnings Roundup: Cardinal Health (NYSE:CAH) And The Rest Of The Healthcare Providers & Services Segment
  Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including Cardinal Health (NYSE:CAH) and its peers.
  Mar 4, 2026 - $CAH
• Cryoport, Inc. Q4 2025 Earnings Call Summary
  Moby summary of Cryoport, Inc.'s Q4 2025 earnings call
  Mar 4, 2026 - $CAH
• Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
  Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
  Mar 3, 2026 - $CAH